Comparison of efficacy and safety of thermal ablation and cryotherapy for symptomatic cervical ectropion

Comparison of efficacy and safety of thermalablation and cryotherapy for symptomatic cervical ectropion - -

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082153

Enrollment

Registered

2025-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N86- Erosion and ectropion of cervix uteri

Interventions

Intervention1: Thermal ablation: Assessing safety and efficacy of thermal ablation on patients which will be women suffering with symptomatic cervical ectropion in one sitting and comparing with cryot

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age 20 to 50 years Patients who will be willing for study and symptoms like persistent vaginal discharge bleeding itching

Exclusion criteria

Exclusion criteria: Patients not giving consent for study or pregnant females or abnormal cervical cytological screening or abnormal histopthology reports

Design outcomes

Primary

Measure	Time frame
Symptomatic relief and presence of cervical ectropion on per speculum examinationTimepoint: 6 weeks and 6 months after intervention	—

Secondary

Measure	Time frame
Persistence of discharge or not presence of pain presence of post coital bleeding recurrence of cervical ectropion on per speculum examination Timepoint: 6 weeks 6 months after intervention	—

Countries

India

Contacts

Public ContactDr. Manjulata Verma

King Georges medical university Lucknow

gaganmlv@gmail.com9721250092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026